Health-Related Quality of Life (HRQoL) in Patients with Relapsed and Refractory Multiple Myeloma (RRMM) Who Are Triple-Class Exposed to an Immunomodulatory Agent, a Proteasome Inhibitor, and an Anti-CD38 Antibody
| Autor: | Shah, Nina, Vij, Ravi *, Roberts, Jenna S. *, Rajkovic, Ivana *, Silbermann, Rebecca, Hillengass, Jens, Dhanasiri, Sujith *, Braverman, Julia *, McMillan, Abigail *, Dhanda, Devender * |
|---|---|
| Zdroj: | In Blood 15 November 2022 140 Supplement 1:13259-13261 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|